Publications

If AWS and Azure are designated under the DMA, the law’s intentional targeting of U.S. tech platforms will be almost impossible to hide.

Bill C-34 gives platforms a reason to design safer services for children. But sequencing matters: If Ottawa brings the restriction into force before the Digital Safety Commission is operational, the fastest path to compliance will be removing the very users the bill means to protect.

Overly restrictive spectrum allocations have left terrestrial bands underutilized. Regulators should not repeat those mistakes as they develop new policies for the orbital economy.

U.S. visa policies are limiting the flow of foreign expertise that is critical to strengthening American manufacturing, innovation, and scientific leadership. Congress should create a dedicated visa category with expedited processing for technical experts and researchers who advance U.S. industrial competitiveness.

Innovation not only gives rise to market power, but market power fosters innovation by enabling and incentivizing the firms that possess it to make the investments innovation requires.

Fears that AI will trigger widespread job losses are increasingly contradicted by new evidence showing that firms adopting AI intensively hire more workers—including entry-level employees—and expand employment across a wide range of occupations. Rather than slowing AI adoption, policymakers should accelerate it through a national AI strategy while pushing back against misleading narratives that undermine productivity, competitiveness, and economic growth.

Foreign governments increasingly use online speech laws to pressure U.S. platforms into censoring constitutionally protected content, while sovereign immunity leaves American companies with little legal recourse. Wyoming's GRANITE Act offers a promising model, but meaningful protection will ultimately require Congress to amend federal sovereign immunity laws.

In a survey of 1,000 U.S. researchers supported by the National Institutes of Health (NIH), 13 percent said that their labs had lost researchers to other countries as a result of NIH funding changes, while 14 percent reported that immigration policies forced scientists, students, and postdocs to turn down offers to work in NIH-supported labs.

Canadian, Mexican, and U.S. trade negotiators should view the USMCA renewal process as an opportunity to move beyond the old free-trade model and build a strategic North American economic bloc capable of producing, innovating, and competing at the scale required by the China challenge.

China has become an increasingly capable competitor in the global biopharmaceutical industry. To remain competitive, the United States should double down on policies to ensure that it offers the world’s leading environment to support private sector life sciences innovation.